Patients' decision making to accept or decline an implantable cardioverter defibrillator for primary prevention of sudden cardiac death

被引:35
|
作者
Carroll, Sandra L. [1 ]
Strachan, Patricia H. [1 ]
de Laat, Sonya [1 ]
Schwartz, Lisa [2 ]
Arthur, Heather M. [3 ]
机构
[1] McMaster Univ, Sch Nursing, Hamilton, ON L8S 4K1, Canada
[2] McMaster Univ, Arnold L Johnson Chair Hlth Care Eth, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4K1, Canada
[3] McMaster Univ, Michael G DeGroote Endowed Chair Cardiovasc Nursi, Heart & Stroke Fdn Ontario, Sch Nursing, Hamilton, ON L8S 4K1, Canada
基金
加拿大健康研究院;
关键词
cardiovascular; implantable defibrillator; patient decision making; patient values; primary prevention; sudden cardiac death; SURVIVAL;
D O I
10.1111/j.1369-7625.2011.00703.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Patients are offered implantable defibrillators (ICDs) for the prevention of sudden cardiac death (SCD). However, patients' decision-making process (DMP) of whether or not to accept an ICD has not been explored. We asked patients about their decision making when offered an ICD. Design/Setting A grounded theory methodology was employed. Patients were recruited from three ICD centres. Those who received an ICD underwent interviews the first month after implant. Declining patients had interviews at their convenience. In-depth analysis of transcripts was completed. Identified themes were placed along process pathways in a DMP model and tested. Findings Forty-four patients consented to participate (25% women). Thirty-four accepted an ICD and 10 (23%) declined. Ages ranged from 26 to 87 (mean=65; SD=12.5). Participants were retired (65%), had ischaemic heart disease (64%) and some post-secondary education (52%). The DMP was triggered when patient's risk for SCD was communicated. The physician's recommendation and a new awareness SCD risk were motivators to accept the ICD. Patient's decision-making approaches fell along a continuum, from active and engaged to passive and indifferent. Patient's approaches were influenced most by the following: (i) trust; (ii) social influences and (iii) health state. Conclusions Health-care providers need to recognize the DMP pathways in which ICD candidacy and SCD risk are understood. The factors that influence a patient's decision warrant discussion pre-implant. It is imperative that patients comprehend the meaning of ICD candidacy to make an informed decision. Participants did not recall alternatives to receiving ICD therapy.
引用
收藏
页码:69 / 79
页数:11
相关论文
共 50 条
  • [41] Sex Differences in Outcomes of Patients with an Implantable Cardioverter-Defibrillator for the Secondary Prevention of Sudden Cardiac Death
    Noordman, Alwin B. P.
    Rienstra, Michiel
    Blaauw, Yuri
    Mulder, Bart A.
    Maass, Alexander H.
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2024, 11 (04)
  • [42] THE AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR FOR PREVENTION OF SUDDEN CARDIAC DEATH IN CHILDREN AND ADOLESCENTS
    PAUL, T
    LUHMER, I
    TRAPPE, HJ
    KLEIN, H
    FIEGUTH, HG
    BRAUER, C
    SCHARPWINKEL, U
    KALLFELZ, HC
    ZEITSCHRIFT FUR KARDIOLOGIE, 1993, 82 (08): : 466 - 473
  • [43] Medications Are Important for Sudden Cardiac Death Prevention But So Is the Implantable Cardioverter-Defibrillator
    Al-Khatib, Sana M.
    Blumer, Vanessa
    Felker, G. Michael
    JACC-HEART FAILURE, 2020, 8 (10) : 856 - 858
  • [44] A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death
    Tung, Roderick
    Zimetbaum, Peter
    Josephson, Mark E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (14) : 1111 - 1121
  • [45] Prevention of sudden cardiac death in patients with chronic kidney disease: risk and benefits of the implantable cardioverter defibrillator
    Jana M. Hoffmeister
    N. A. Mark Estes
    Ann C. Garlitski
    Journal of Interventional Cardiac Electrophysiology, 2012, 35 : 227 - 234
  • [46] Prevention of sudden cardiac death in patients with chronic kidney disease: risk and benefits of the implantable cardioverter defibrillator
    Hoffmeister, Jana M.
    Estes, N. A. Mark, III
    Garlitski, Ann C.
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2012, 35 (02) : 227 - 234
  • [47] Primary hyperparathyroidism and arrhythmic storm in a patient with an implantable cardioverter defibrillator for primary prevention of sudden death
    Occhetta, E
    Bortnik, M
    Magnani, A
    Francalacci, G
    Vassanelli, C
    EUROPACE, 2004, 6 (03): : 184 - 188
  • [48] Impact of a hybrid decision support system to improve the adherence to implantable cardioverter defibrillator therapy guidelines for primary prevention of sudden cardiac death
    Vecchio, Nicolas
    Belardi, Diego
    Benzadon, Mariano
    Seoane, Leonardo
    Daquarti, Gustavo
    Scazzuso, Fernando
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2018, 114 : 76 - 80
  • [49] Sudden cardiac death: a critical appraisal of the implantable cardioverter defibrillator
    Rajabali, A.
    Heist, E. K.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (04) : 458 - 464
  • [50] PRIMARY PREVENTION OF SUDDEN DEATH WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IN PATIENTS WITH DILATED CARDIOMYOPATHY OF CHAGASIC ETIOLOGY
    Velasco, Sergio
    Mora Pabon, Guillermo
    Alberto Cortes, Jorge
    Guarnizo, Mayra
    Olaya, Alejandro
    Diaz, Andres
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 541 - 541